Search

everythinglearnresearchcommunity

for

Search:↓

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

PlacMA hydrogels from human placenta are versatile and useful for cell culture and tissue engineering.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Gene therapy with the Math1 gene helped regenerate balance-related cells and improve balance in mice.

Oxidative stress contributes to hair graying and loss as we age.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

The research identified various cell types in mouse and human teeth, which could help in developing dental regenerative treatments.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.